Recombinant Human PVRIG Protein (N-6xHis-SUMO)
Beta LifeScience
SKU/CAT #: BLC-11443P

Greater than 85% as determined by SDS-PAGE.
Recombinant Human PVRIG Protein (N-6xHis-SUMO)
Beta LifeScience
SKU/CAT #: BLC-11443P
Collections: Recombinant proteins, Recombinant proteins holiday sale
Regular price
$94900
$949.00
Sale price$34900
$349.00Save $600
/
Submit an inquiry or email sales for a custom bulk quote. Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
Description | Explore the potential of the Recombinant Human PVRIG protein, an invaluable resource for advancing your cell biology research. PVRIG, also referred to as the CD112 receptor or Poliovirus receptor-related immunoglobulin domain-containing protein, plays a critical role in diverse cellular processes. Our product is synthesized using an advanced in vitro E.coli expression system, ensuring consistent and reliable production of the protein. This exceptional product encompasses the full length of the PVRIG protein, spanning amino acids 1 to 326. It features an N-terminal 6xHis-SUMO tag, facilitating easy detection and purification, streamlining your experimental workflows. With a purity level exceeding 85% as determined by SDS-PAGE, you can rely on its exceptional quality to deliver consistent and reproducible results in your research. |
Purity | Greater than 85% as determined by SDS-PAGE. |
Uniprotkb | Q6DKI7 |
Target Symbol | PVRIG |
Species | Human |
Expression System | in vitro E.coli expression system |
Tag | N-terminal 6xHis-SUMO-tagged |
Target Protein Sequence | MRTEAQVPALQPPEPGLEGAMGHRTLVLPWVLLTLCVTAGTPEVWVQVRMEATELSSFTIRCGFLGSGSISLVTVSWGGPNGAGGTTLAVLHPERGIRQWAPARQARWETQSSISLILEGSGASSPCANTTFCCKFASFPEGSWEACGSLPPSSDPGLSAPPTPAPILRADLAGILGVSGVLLFGCVYLLHLLRRHKHRPAPRLQPSRTSPQAPRARAWAPSQASQAALHVPYATINTSCRPATLDTAHPHGGPSWWASLPTHAAHRPQGPAAWASTPIPARGSFVSVENGLYAQAGERPPHTGPGLTLFPDPRGPRAMEGPLGVR |
Expression Range | 1-326aa |
Protein Length | Full Length |
Mol. Weight | 50.3 kDa |
Research Area | Cell Biology |
Form | Liquid or Lyophilized powder |
Buffer | Liquid form: default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0. |
Reconstitution | Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
Storage | 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
Notes | Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week. |
Target Function | Cell surface receptor for NECTIN2. May act as a coinhibitory receptor that suppresses T-cell receptor-mediated signals. Following interaction with NECTIN2, inhibits T-cell proliferation. Competes with CD226 for NECTIN2-binding. |
Subcellular Location | Cell membrane; Multi-pass membrane protein. |
Database References |
HGNC: 32190 OMIM: 617012 KEGG: hsa:79037 STRING: 9606.ENSP00000316675 UniGene: Hs.729356 |
Tissue Specificity | Expressed in some types of immune cells. Expressed at low levels on the surface of freshly isolated T-cells and natural killer (NK) cells, predominantly on CD8+ T-cells (mainly memory/effector, but not naive cells) and on both CD16+ and CD16- NK cells. T- |